Inflammatix is a healthcare technology company based in Sunnyvale, California. Founded in 2016, the company’s flagship product, the TriVerity test system designed for early detection of acute viral and bacterial infections, received FDA breakthrough designation last November. The test system leverages machine learning algorithms to detect infections as well as the severity of the infection based on standard biomarkers and give results in 30 minutes.